Airway Therapeutics
is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory and inflammatory diseases... Read moreAirway Therapeutics
is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory and inflammatory diseases... Read more
President & CEO
Marc Salzberg
News
Aug 12, 2025
FinanzNachrichten
Airway Therapeutics: Airway Therapeutics Receives European Medicines Agency Pediatric Committee Approval for Zelpultide Alfa's Study Plan in Bronchopulmonary Dysplasia for Very Preterm Infants
Oct 15, 2024
Yahoo
Airway Therapeutics: Airway Therapeutics to Launch a Multinational Phase 3 Trial of Zelpultide Alfa for Preterm Neonates at Risk of Bronchopulmonary Dysplasia
Jun 24, 2024
Yahoo
Airway Therapeutics: Airway Therapeutics Wins 2024 ATS Whitsett Award for Abstract of Positive Phase 1b Results of Zelpultide Alfa in Preterm Neonates at Risk of Bronchopulmonary Dysplasia
Jun 04, 2023
Acrofan
Airway Therapeutics: Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
Apr 11, 2023
Clinical Trials Arena
Airway Therapeutics: Airway completes Phase Ib BPD therapy trial's dose escalation portion
Oct 04, 2022
Clinical Trials Arena
Airway Therapeutics: Airway doses first subject in bronchopulmonary dysplasia trial in Spain
Mar 31, 2022
Markets Insider
Airway Therapeutics: Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)
Aug 31, 2021
The Business Journals: Cincinnati Business Courier
Airway Therapeutics: First patient dosed in startup's key Covid-19 clinical trial
Aug 26, 2021
PR Newswire
Press Release: Airway Therapeutics : Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Severe COVID-19 Patients
Apr 13, 2021
Pharamceutical Technology
Airway Therapeutics: FDA accepts Airway Therapeutics' IND application for Covid-19
Airway Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10